HELIOS-B trial Vutrisiran in ATTR cardiac Amyloidosis - 42 months’ follow-up - composite risk of all-cause mortality and recurrent cardiovascular events was lower in patients on vutrisiran versus placebo in the overall population (HR 0.72; 95% CI 0.56-0.93) #ESCCongress2024

Who needs silent disco when you have silent conference 🪩 #ESCCongress2024

BedMed meta-analysis: no significant differences in MACE between evening vs morning administration of antihypertensives #ESCCongress2024

Watching TV at the #ESC with Joy Ong Learning can’t get more chill than this! #ESCCongress2024

Looking at the amazing number of attendees from NUHCS nuh and nus at esc London ! We are the biggest group among the three healthcare clusters also with record breaking of 18 abstracts presented in the last four days here in London 🤩

Non Gl causes of vomiting 🤮

#NUHCS proudly presented a record-breaking 18 oral abstracts from SG, at European Society of Cardiology Congress 2024. Focused on personalising cardiovascular care to improve patient outcomes, our team continues to advance cardiac care via research & collaboration to shape the future of CV medicine.

Bedside ECHO/POCUS Cathy Cichon #MedEd

💥AMIODARONE is a class III antiarrhythmic drug which is widely used in ER for treating arrhythmias. A 🧵 on situations where blind use of amiodarone in emergency can be counterproductive ⚠️⚠️⚠️ With alternate therapeutic options Read on...👇 #MedTwitter #MedEd #MedX

Our systematic review of eight clinical trials, including 11,436 post-AMI patients, found that initiating SGLT2i reduced heart failure hospitalizations and lowered NT-proBNP levels. Jamie S. Y. Ho Yao Hao Teo Mark Chan NUHCS - National University Heart Centre,Singapore Yong Loo Lin School of Medicine Article avail at: doi.org/10.1007/s40256…

Heart failure’s rising global incidence calls for new treatments. Research into epigenetic mechanisms—like DNA methylation & histone modifications—shows promise for understanding & targeting heart failure. Article avail at: mdpi.com/1422-0067/25/2…

Exploring Simultaneous Stroke and Heart Attack in a National Dataset #BloggingStroke contributor Alice Hosking discusses #Stroke article by Jamie S. Y. Ho and Zheng et al. #AHAJournals leonard yeo Mark Chan StroCar: elucidating heart-brain interactions Ching-Hui SIA Benjamin Tan ahajournals.org/do/10.1161/blo…

🔴Echocardiography and Pulmonary Embolism ⤵️ #2024Review 🔹link.springer.com/10.1007/978-3-… #POCUS #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical

Some 🔑 numbers when considering NT-proBNP in heart failure #MedTwitter #CardioTwitter #MedEd #FOAMed European Society of Cardiology Journals

EECP therapy improves cerebral blood flow in symptomatic severe intracranial stenosis. Dr Vijay Sharma and Dr May Zin presented our RCT findings today at #ESOC2025. Larger validation studies needed!

Comparison of vericiguat for HFrEF in the new VICTOR trial with other therapies #ESC2025

Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: thelancet.com/journals/lance…

Esc the biggest cardiovascular meeting in world where researchers n clinicians meet science

After 30 years of primary PCI we now have an objective definition of the most common #ECG pattern of STEMI. Hyperacute T-waves specific for acute coronary occlusion now defined using #AI in JACC Journals!

Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology: JACC Journals and American College of Cardiology 🥸 Inflammation and aging are interlinked: #inflammaging 😱 Great science statement here 👇👇👇